Assignee
EXPRESSION PATHOLOGY INC
US·36 granted patents·24 pending applications·168 citations·filing 2004–2019
Top patents by PatentIndex Score
60 records- 0197US7473532B2Liquid tissue preparation from histopathologically processed biological samples, tissues and cellsEXPRESSION PATHOLOGY INC·Filed 2004·Granted Jan 6, 2009·129 cites·15 claims
- 0286US10101334B2Multiplex MRM assay for evaluation of cancerEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 16, 2018·2 cites·21 claims
- 0386US9261506B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 16, 2016·4 cites·14 claims
- 0485US9746477B2Quantifying FR-α and GART proteins for optimal cancer therapyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 29, 2017·11 cites·17 claims
- 0583US10203336B2SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) proteinEXPRESSION PATHOLOGY INC·Filed 2015·Granted Feb 12, 2019·2 cites·19 claims
- 0683US9360487B2Multiplex MRM assay for evaluation of cancerEXPRESSION PATHOLOGY INC·Filed 2014·Granted Jun 7, 2016·3 cites·17 claims
- 0781US10060927B2SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 28, 2018·2 cites·14 claims
- 0880US9163275B2Liquid tissue preparation from histopathologically processed biologically samples, tissues and cellsEXPRESSION PATHOLOGY INC·Filed 2013·Granted Oct 20, 2015·2 cites·5 claims
- 0978US9309554B2SRM/MRM assay for the fatty acid synthase proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Apr 12, 2016·2 cites·9 claims
- 1077US9139864B2c-Src selected reaction monitoring assayEXPRESSION PATHOLOGY INC·Filed 2013·Granted Sep 22, 2015·2 cites·16 claims
- 1176US10073075B2SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 11, 2018·1 cites·14 claims
- 1276US7906301B2Multiplex method for increased proteomic coverage from histopathologically processed biological samples, tissues cellsEXPRESSION PATHOLOGY INC·Filed 2006·Granted Mar 15, 2011·4 cites·14 claims
- 1373US2019368986A1Liquid tissue preparation from histopathological processed biological samples, tissues and cellsEXPRESSION PATHOLOGY INC·Filed 2019·Application pending·0 cites
- 1472US10126307B2SRM/MRM assay for the androgen receptor (AR) proteinEXPRESSION PATHOLOGY INC·Filed 2015·Granted Nov 13, 2018·1 cites·12 claims
- 1571US10202635B2SRM/MRM assay for the ephrin type-A receptor 2 proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 12, 2019·1 cites·11 claims
- 1671US9840728B2SRM assay to indicate cancer therapyEXPRESSION PATHOLOGY INC·Filed 2015·Granted Dec 12, 2017·1 cites·13 claims
- 1771US9470696B2SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4)EXPRESSION PATHOLOGY INC·Filed 2014·Granted Oct 18, 2016·1 cites·17 claims
- 1867US10718780B2SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) proteinEXPRESSION PATHOLOGY INC·Filed 2019·Granted Jul 21, 2020·0 cites·16 claims
- 1965US10577641B2Truncated Her2 SRM/MRM assayEXPRESSION PATHOLOGY INC·Filed 2017·Granted Mar 3, 2020·0 cites·19 claims
- 2065US10444126B2Liquid tissue preparation from histopathologically processed biological samples, tissues and cellsEXPRESSION PATHOLOGY INC·Filed 2015·Granted Oct 15, 2019·0 cites·9 claims
- 2164US9766246B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 19, 2017·0 cites·12 claims
- 2263US9255934B2SRM/MRM assay for the insulin receptor proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Feb 9, 2016·0 cites·18 claims
- 2362US9442119B2MRM/SRM assay for death receptor 5 proteinEXPRESSION PATHOLOGY INC·Filed 2014·Granted Sep 13, 2016·0 cites·10 claims
- 2461US10215761B2Bcl-2-like protein 11 SRM/MRM assayEXPRESSION PATHOLOGY INC·Filed 2016·Granted Feb 26, 2019·0 cites·7 claims
- 2561US9804169B2MRM/SRM assay for death receptor 5 proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 31, 2017·0 cites·3 claims
- 2661US9470687B2SRM/MRM assay for subtyping lung histologyEXPRESSION PATHOLOGY INC·Filed 2015·Granted Oct 18, 2016·0 cites·12 claims
- 2760US10041961B2SRM/MRM assay for the insulin receptor proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 7, 2018·0 cites·21 claims
- 2860US9804164B2SRM/MRM assay for the fatty acid synthase proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Oct 31, 2017·0 cites·6 claims
- 2959US2018136218A1Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM AssayEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 3057US2013011408A1Epidermal Growth Factor Receptor (EGFR) Protein SRM AssayEXPRESSION PATHOLOGY INC·Filed 2012·Application pending·0 cites
- 3156US2017248608A1Epidermal Growth Factor Receptor (EGFR) Protein SRM AssayEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 3253US10620223B2SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Apr 14, 2020·0 cites·13 claims
- 3352US10078084B2SRM/MRM assay for the mesothelin (MSLN) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 18, 2018·0 cites·14 claims
- 3451US10302656B2CMET protein SRM/MRM assayEXPRESSION PATHOLOGY INC·Filed 2016·Granted May 28, 2019·0 cites·12 claims
- 3550US10537576B2Methods for treating Her2-positive breast cancerEXPRESSION PATHOLOGY INC·Filed 2016·Granted Jan 21, 2020·0 cites·16 claims
- 3649US2018195107A1SRM Assay to Indicate Cancer TherapyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 3748US10054592B2Insulin receptor substrate 1 (IRS1) protein SRM/MRM assayEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 21, 2018·0 cites·6 claims
- 3846US10585099B2SRM/MRM assays for cancerEXPRESSION PATHOLOGY INC·Filed 2017·Granted Mar 10, 2020·0 cites·9 claims
- 3946US2013079425A1Urokinase-Type Plasminogen Activator Protein /Plasminogen Activator Inhibitor Type-1 Protein Selected Reaction Monitoring AssayEXPRESSION PATHOLOGY INC·Filed 2012·Application pending·0 cites
- 4044US2018112277A1Signal directed dissection to inform cancer therapy strategyEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4143US2011028344A1Biomarkers for endometrial diseaseEXPRESSION PATHOLOGY INC·Filed 2009·Application pending·0 cites
- 4242US10617717B2Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapyEXPRESSION PATHOLOGY INC·Filed 2017·Granted Apr 14, 2020·0 cites·10 claims
- 4342US10208130B2Quantifying Her2 protein for optimal cancer therapyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Feb 19, 2019·0 cites·16 claims
- 4442US2017122953A1SRM/MRM Assay for the Serine/Threonine-Protein Kinase B-RAF (BRAF)EXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4542US2017122946A1SRM/MRM Assay for the GTPase KRas Protein (KRas)EXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4642US2018172690A1Method for improved hepatocellular cancer diagnosisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4742US2020132694A1SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) ProteinEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4842US2019353658A1Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic AnalysisEXPRESSION PATHOLOGY INC·Filed 2017·Application pending·0 cites
- 4941US10288616B2Quantifying met protein for cancer treatmentEXPRESSION PATHOLOGY INC·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 5041US2020132696A1SRM/MRM Assays For Notch Pathway ProteinsEXPRESSION PATHOLOGY INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when EXPRESSION PATHOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →